Diabetes

Top Story

Abbott to acquire St. Jude Medical

April 28, 2016

Abbott announced that it will acquire St. Jude Medical in an effort to enhance its global scale and diversify its portfolio.

With the acquisition, Abbott will become a “premier medical device leader with top positioning in high-growth [CV] markets, including AF, structural heart and HF as well as a leading position in the high-growth neuromodulation market,” the company stated in a press release.

Meeting News Coverage

PEGASUS-TIMI 54: Long-term ticagrelor benefits patients with history of MI, diabetes, PAD

April 28, 2016
CHICAGO — Two subanalyses of the PEGASUS-TIMI 54 study of stable patients with prior MI showed that ticagrelor reduced major adverse CV events in patients with a…
In the Journals

Lipid-lowering therapy reduces risk for CVD, death in type 1 diabetes

April 26, 2016
People with type 1 diabetes without a history of cardiovascular disease may have reduced risk for cardiovascular disease and cardiovascular death with the use of…
In the Journals

Healthy diet may reduce hypertension risk in women with gestational diabetes

April 21, 2016
Women with gestational diabetes were 20% less likely to develop hypertension later in life if they maintained a healthy diet, researchers reported in…
CME

The High-risk Patient with Dyslipidemia

No commercial support for this activity.

As many as 40% to 50% of Americans are estimated to have lipid abnormalities including elevated low-density lipoprotein…
More »
Video
Meeting News Coverage

VIDEO: Recent advances in diabetes highlighted at Cardiometabolic Health Congress

October 22, 2015
More »
Featured
Video
Meeting News Coverage

VIDEO: Diabetes may be risk equivalent for PAD, CAS

April 3, 2016
More »

Abbott to acquire St. Jude Medical

April 28, 2016
Abbott announced that it will acquire St. Jude Medical in an effort to enhance its global scale and diversify its portfolio.With the acquisition…
Meeting News Coverage

PEGASUS-TIMI 54: Long-term ticagrelor benefits patients with history of MI, diabetes, PAD

April 28, 2016
CHICAGO — Two subanalyses of the PEGASUS-TIMI 54 study of stable patients with prior MI showed that ticagrelor reduced major adverse CV events…
In the Journals

Lipid-lowering therapy reduces risk for CVD, death in type 1 diabetes

April 26, 2016
People with type 1 diabetes without a history of cardiovascular disease may have reduced risk for cardiovascular disease and cardiovascular death…
In the Journals

Healthy diet may reduce hypertension risk in women with gestational diabetes

April 21, 2016
Women with gestational diabetes were 20% less likely to develop hypertension later in life if they maintained a healthy diet, researchers reported in…
Meeting News Coverage

Major bleeding risk low in real-world study of high-risk users of rivaroxaban

April 20, 2016
CHICAGO — A postmarketing study of users with nonvalvular atrial fibrillation taking rivaroxaban confirms that the real-world risk for major…
Meeting News CoverageVideo

VIDEO: PEGASUS-TIMI 54 analysis shows reduced risk for MACE in patients with diabetes

April 7, 2016
CHICAGO — At the American College of Cardiology Scientific Session, Deepak L. Bhatt, MD, MPH, provides investigator insight on a new…
Meeting News Coverage

STAMPEDE: Glycemic benefits of bariatric surgery sustained up to 5 years

April 6, 2016
CHICAGO — Patients with mild to moderate obesity and type 2 diabetes who underwent bariatric surgery had better glycemic control than patients…
Meeting News CoverageVideo

VIDEO: Diabetes may be risk equivalent for PAD, CAS

April 3, 2016
CHICAGO — In this video exclusive, Jeffrey S. Berger, MD, discusses new research on the prevalence of peripheral artery disease and carotid…
In the Journals

CTOs linked to mortality in patients with CAD, diabetes

March 31, 2016
In patients with CAD and diabetes, the presence of chronic total occlusion of coronary arteries was linked to increased mortality in patients…

Alirocumab reduces need for apheresis therapy

March 26, 2016
Sanofi and Regeneron announced positive topline results of from the ODYSSEY ESCAPE trial demonstrating that the addition of alirocumab to weekly or…
More Headlines »
morganatic-roan
morganatic-roan